The expression levels of oncogenes, including SMAD4, IGF1, GRB10, BCL2, CCND1, MYC, AKT3, TGFBR2, and CYCS, were significantly increased in the rectal cancer patients compared to the control group. The gene discussed is TGFBR2; the disease is rectal cancer.